Rifadin, Rifampin capsules, 150 mg, packaged in 30-count bottle, Rx only, Mfd. for Sanofi-Aventis, U.S., LLC, Bridgewater, NJ 08807, NDC 0068-0510-30

FDA recall notice · announced August 14, 2013 · Sanofi Us

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

Rifadin, Rifampin capsules, 150 mg, packaged in 30-count bottle, Rx only, Mfd. for Sanofi-Aventis, U.S., LLC, Bridgewater, NJ 08807, NDC 0068-0510-30

Reason for recall

Subpotent drug: low fill volume in some of the capsules

Notes

Distribution: Nationwide
Lot/code information: Lot # 3097657, Exp 3/15
Quantity: 2,462 bottles
Status: Terminated
Products in this recall event:
- Rifadin, Rifampin capsules, 150 mg, packaged in 30-count bottle, Rx only, Mfd. for Sanofi-Aventis, U.S., LLC, Bridgewater, NJ 08807, NDC 0068-0510-30 (D-841-2013)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.